Unlocking the potential of Tregs: innovations in CAR technology

Regulatory T cells (Tregs) adoptive immunotherapy is emerging as a viable treatment option for both autoimmune and alloimmune diseases. However, numerous challenges remain, including limitations related to cell number, availability of target-specific cells, stability, purity, homing ability, and saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Requejo Cier, Christopher J., Valentini, Nicolas, Lamarche, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602912/
https://www.ncbi.nlm.nih.gov/pubmed/37900916
http://dx.doi.org/10.3389/fmolb.2023.1267762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602912/
https://www.ncbi.nlm.nih.gov/pubmed/37900916
http://dx.doi.org/10.3389/fmolb.2023.1267762

Ejemplares similares